Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 17 of 6351
-
New hope for kids with blood cancer: tailored treatments aim to boost cure rates and cut side effects
Disease control OngoingThe overarching objective of this study is to use novel precision medicine strategies based on inherited and acquired leukemia-specific genomic features and targeted treatment approaches to improve the cure rate and quality of life of children with acute lymphoblastic leukemia (A…
Phase 2/3 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for kids with leukemia: smarter chemo dosing could boost cures
Cure OngoingAcute lymphoblastic leukemia (ALL) is the most common cancer diagnosed in children. The cancer comes from a cell in the blood called a lymphocyte. Normal lymphocytes are produced in the bone marrow (along with other blood cells) and help fight infections. In ALL, the cancerous ly…
Phase 3 • Sponsor: Dana-Farber Cancer Institute • Aim: Cure
Last updated Jul 18, 2026 00:00 UTC
-
Can an 8-Week pill regimen cure hepatitis c?
Cure CompletedA Phase 3, Global, Multicenter, Open-Label Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, with non-severe fibrosis The primary objectives of this study are as follows: * To evaluate th…
Phase 3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Cure
Last updated Aug 26, 2026 00:00 UTC
-
Could a common painkiller stop breast cancer from returning?
Prevention Stopped earlyThis randomized phase III trial studies how well aspirin works in preventing the cancer from coming back (recurrence) in patients with human epidermal growth factor receptor 2 (HER2) negative breast cancer after chemotherapy, surgery, and/or radiation therapy. Aspirin is a drug t…
Phase 3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
HIV prevention breakthrough: a shot every two months could replace daily pills
Prevention CompletedThis study will evaluate the safety and efficacy of the injectable drug cabotegravir (CAB LA), for pre-exposure prophylaxis (PrEP) in HIV-uninfected cisgender men and transgender women who have sex with men (MSM and TGW).
Phase 2/3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC
-
One pill to cure sleeping sickness? new trial raises hopes
Cure CompletedThe goal of this study is to assess efficacy and safety of acoziborole in adult participants with Trypanosoma brucei gambiense (T.b. gambiense) HAT, either early- or intermediate-stage HAT (first arm) or late-stage HAT (second arm). Participants will receive 3 tablets of 320 mg a…
Phase 2/3 • Sponsor: Drugs for Neglected Diseases • Aim: Cure
Last updated Jun 26, 2026 17:39 UTC
-
Gene therapy trial aims to fix 'Bubble Boy' disease in newborns
Disease control PausedSCID-X1 is a genetic disorder of blood cells caused by DNA changes in a gene that is required for the normal development of the human immune system. The purpose of this study is to determine if a new method, called lentiviral gene transfer, can be used to treat SCID-X1. This meth…
Phase 1/2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Spinal implant + robot rehab: a new hope for walking after injury?
Disease control CompletedSTIMO is a First-in-Man (FIM) study to confirm the safety and feasibility of a closed-loop Epidural Electrical Stimulation (EES) in combination with overground robot assisted rehabilitation training for patients with chronic incomplete spinal cord injury (SCI). Patients will par…
Sponsor: Jocelyne Bloch • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Dengue vaccine shows promise in massive child trial
Vaccine CompletedThe main purpose of this study is to evaluate the efficacy of 2 doses of Tetravalent Dengue Vaccine Candidate (TDV) in preventing symptomatic dengue fever of any severity and due to any of the four dengue virus serotypes in 4 to 16 year old participants.
Phase 3 • Sponsor: Takeda • Aim: Vaccine
Last updated Jun 27, 2026 07:57 UTC
-
Can tailored chemotherapy tame leukemia in down syndrome?
Disease control OngoingThis phase III trial studies response-based chemotherapy in treating newly diagnosed acute myeloid leukemia or myelodysplastic syndrome in younger patients with Down syndrome. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing …
Phase 3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can Lab-Grown skin permanently replace severe burn wounds?
Cure Recruiting nowThis clinical trial is designed to assess the safety, effectiveness and benefits of Self Assembled Skin Substitute SASS grafts as a permanent skin replacement for the treatment of full-thickness burn wounds that require permanent coverage where the availability of donor sites is …
Phase 1/2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Cure
Last updated Aug 07, 2026 00:00 UTC
-
Major trial tests cutting radiation for kids with hodgkin lymphoma
Cure CompletedThe EuroNet-PHL-C2 trial is an international, multicentre, randomised controlled trial with the aims to reduce the indication for radiotherapy in newly diagnosed patients with classical Hodgkin lymphoma without compromising cure rates and to investigate a chemotherapy intensifica…
Phase 3 • Sponsor: University of Giessen • Aim: Cure
Last updated Jun 27, 2026 12:01 UTC
-
New drug shrinks tumors in patients with rare gene mutation
Disease control CompletedThis research study is done to test how well different types of cancer respond to the drug called larotrectinib. The cancer must have a change in a particular gene (NTRK1, NTRK2 or NTRK3). Larotrectinib is a drug that blocks the actions of these NTRK genes in cancer cells and can…
Phase 2 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Spinal injection drug shows promise in stopping SMA before symptoms start
Disease control CompletedThe primary objective of the study is to examine the efficacy of multiple doses of Nusinersen administered intrathecally in preventing or delaying the need for respiratory intervention or death in infants with genetically diagnosed and presymptomatic spinal muscular atrophy (SMA)…
Phase 2 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Penis transplants could restore form and function for wounded warriors
Disease control Recruiting nowInjuries to the genitalia are of concern to the military with emphasis placed on the surgical reconstruction and psychological health of these Wounded Warriors. However, despite significant surgical advances in microvascular surgery and autologous free tissue transfer, convention…
Phase 2/3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
A gentler transplant may cure sickle cell and thalassemia — can the body accept donor cells?
Cure OngoingBackground: \- Some sickle cell disease or beta-thalassemia can be cured with transplant. Researchers want to test a variation of transplant that uses low dose radiation and a combination of immunosuppressive drugs. They want to know if it helps a body to better accept donor ste…
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Cure
Last updated Aug 20, 2026 00:00 UTC
-
Could a drug stop Alzheimer's before symptoms start?
Prevention CompletedThe purpose of this study is to test whether an investigational drug called solanezumab can slow the progression of memory problems associated with brain amyloid (protein that forms plaques in the brains of people with Alzheimer Disease \[AD\]).
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Prevention
Last updated Aug 23, 2026 00:00 UTC
-
Can a daily pill keep BRCA-Linked ovarian cancer at bay?
Disease control OngoingA Phase III, randomised, double-blind, placebo-controlled, multi-centre study to assess the efficacy of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary peritoneal and / or fallopian tube cancer) or hi…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Personalized leukemia vaccine aims to outsmart relapse
Cure CompletedAcute myelogenous leukemia (AML) arises from leukemia stem cells that are difficult to eradicate and serve as a reservoir for disease relapse following chemotherapy. A promising area of investigation is the development of immunotherapeutic approaches that stimulate the immune sys…
Phase 2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Cure
Last updated Jul 16, 2026 00:00 UTC
-
Gene therapy offers hope for children with rare brain disease
Disease control CompletedThis Phase I/II clinical trial consists of the application of lentiviral vector-based gene therapy to patients affected by Metachromatic Leukodystrophy (MLD), a rare inherited Lysosomal Storage Disorder (LSD) resulting from mutations in the gene encoding the Arylsulfatase A (ARSA…
Phase 1/2 • Sponsor: Orchard Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC